FDA Approves Oncomine Dx Express Test As An In Vitro Diagnostic Assay For Use As Companion Diagnostic For Sunvozertinib In EGFR Exon 20 Insertion Mutation–Positive NSCLC And For Use In Tumor Profiling
- July 08, 2025
You must be logged in to access this content.